Arm 2

DRUG20 trials

Sponsors

VA Office of Research and Development, Amgen, Jonsson Comprehensive Cancer Center, Daniel Moore, Tata Memorial Hospital

Conditions

BRAFCRC (Colorectal Cancer)Carcinoma of Buccal MucosaColorectal CancerFacial RosaceaGoutHIV/AIDSHIV/AIDS Neonatal Diseases Nutritional, Metabolic, Endocrine

Phase 1

Safety Study of Latanoprost Slow Release Insert

TerminatedNCT01180062

Daniel MooreOcular Hypertension (OHT), Primary Open Angle Glaucoma (POAG)

Start: 2011-01-31End: 2014-06-30Updated: 2014-12-08

Phase 2

Effect of COX-2 and EGFR Suppression on Molecular Markers of Angiogenesis and Proliferation in Squamous Cell Carcinoma of Oral Cavity - Prospective Randomized Study

Tata Memorial HospitalCarcinoma of Buccal Mucosa, Head and Neck Cancers, Oral Squamous Cell Carcinoma +1

Start: 2015-08-18End: 2023-04-30Updated: 2022-04-28

Study of of URC102 to Assess the Efficacy and Safety in Gout Patients

CompletedNCT04804111

JW PharmaceuticalGout

Start: 2019-01-21End: 2020-11-29Updated: 2021-03-18

A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis (RAD-TB)

Active, not recruitingPACTR202404734179820

National Institute of Allergy and Infectious DiseasesTuberculosis

Start: 2024-04-01Target: 100Updated: 2026-08-03

A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative Colitis Resistant or Intolerant to Oral Aminosalicylates

CompletedNCT06398808

Zydus Lifesciences LimitedUlcerative Colitis

Start: 2024-04-08End: 2024-11-28Updated: 2024-12-20

Efficacy and Safety of Tunlametinib Combination Therapy in the Treatment of Second-line and Above Metastatic Colorectal Cancer

Not yet recruitingNCT07714447

Sun Yat-sen UniversityBRAF, CRC (Colorectal Cancer)

Start: 2026-11-30End: 2029-02-26Target: 91Updated: 2026-07-21

Phase 3

Study of Panitumumab Efficacy in Patients With Recurrent and/or Metastatic Head and Neck Cancer

CompletedNCT00460265

AmgenRecurrent and/or Metastatic Head and Neck Cancer

Start: 2007-05-31End: 2012-05-31Updated: 2014-03-07

RecruitingPACTR202311478928378

Queen Mary University of LondonHIV/AIDS Neonatal Diseases Nutritional, Metabolic, Endocrine

Start: 2024-01-01Target: 422Updated: 2026-08-03

Phase 4

Pharmacy PrEP cRCT

Active, not recruitingPACTR202302662168727

jhpiegoHIV/AIDS

Start: 2023-04-01Target: 10800Updated: 2026-08-03

Investigating the Optimal Remifentanil and Dexmedetomidine Concentration for Uterine Fibroid Ablation

Not yet recruitingNCT06640738

Kaohsiung Medical UniversityUterine Fibroids (UF)

Start: 2024-10-01End: 2026-10-31Target: 60Updated: 2024-10-15

Unknown Phase

Spinal Cord Injury Vocational Integration Program (SCI-VIP)

CompletedNCT00117806

VA Office of Research and DevelopmentSpinal Cord Injuries

Start: 2006-04-30End: 2011-09-30Updated: 2016-03-03

Increasing Colorectal Cancer Screening Among Filipino Americans

CompletedNCT00742729

Jonsson Comprehensive Cancer CenterColorectal Cancer

Start: 2004-09-30End: 2009-06-30Updated: 2016-08-01

Active, not recruitingPACTR201103000279108

Medical Research CouncilHIV/AIDS Paediatrics

Start: 2011-04-15Target: 64Updated: 2026-08-03

Active, not recruitingPACTR201311000641402

Start: 2012-06-04Target: 230Updated: 2026-08-03

Evaluation of Positioning Protocols on a Wheelchair in Hemiplegic Patients

CompletedNCT04268641

Hôpital NOVOHemiplegia And/or Hemiparesis Following Stroke

Start: 2020-08-28End: 2023-12-11Updated: 2024-09-19

The effectiveness of training models for rural traditional birth attendants in the prevention of mother to child transmission of HIV in Ogun State

Active, not recruitingPACTR202206622552114

Adedoyin OgunyemiHIV/AIDS

Start: 2019-10-01Target: 126Updated: 2026-08-03

tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella)

RecruitingNCT05517135

National Cancer Centre, SingaporeNasopharyngeal Carcinoma

Start: 2022-11-17End: 2027-07-01Target: 1000Updated: 2024-09-19

Brighter Bites & UT Physicians Produce Rx Program

CompletedNCT05556070

The University of Texas Health Science Center, HoustonObesity, Childhood

Start: 2022-10-17End: 2024-11-15Updated: 2024-12-06

Maternal Mental Health Access - MaMa

RecruitingNCT06049433

University of UtahPerinatal Depression, Postpartum Depression

Start: 2023-04-04End: 2025-12-30Target: 120Updated: 2024-12-06

Clinical Study of a Facial Cream for Rosacea

RecruitingNCT07637032

ChinaNormFacial Rosacea

Start: 2026-04-28End: 2026-07-31Target: 76Updated: 2026-06-09

Related Papers

RIBBON-UM: Treatment individualisation by EBV stratification in nasopharyngeal carcinoma (NPC): A phase 2, multi-arm umbrella platform trial.

Journal of Clinical Oncology2025-05-281 citations

Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study

Arthritis Research & Therapy2025-05-26

An adaptive multiarm randomised trial of biomedical and psychosocial interventions to improve convalescence following severe acute malnutrition in sub-Saharan Africa: Co-SAM trial protocol

BMJ Open2025-05-011 citations

Impact of training and case manager support for traditional birth attendants in the linkage of care among HIV-positive pregnant women in Southwest Nigeria: a 3-arm cluster randomized control trial.

2024-02-212 citations

A phase II randomized control trial of erlotinib in combination with celecoxib in patients with operable oral squamous cell carcinoma (OSCC): Erlo-Xib Study.

Journal of Clinical Oncology2019-05-2010 citations

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?

2017-04-0458 citations

A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.

2015-12-0187 citations

Spinal cord injury combined with felony history: Effect on supported employment for Veterans

The Journal of Rehabilitation Research and Development2014-01-015 citations

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

2013-06-06312 citations